Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hans Duvekot is active.

Publication


Featured researches published by Hans Duvekot.


Obstetrics & Gynecology | 2014

Uterine artery pseudoaneurysm requiring embolization during pregnancy.

Jérôme Cornette; Eline van der Wilk; Nina M Janssen; Robin M F van der Weiden; Sjoerd F. Jenninkens; Peter Pattynama; Hans Duvekot

BACKGROUND: Uterine artery pseudoaneurysm has a pathognomonic ultrasound appearance. Its occurrence in pregnancy is life-threatening for both mother and fetus. We present an illustrative case and discuss management with selective uterine artery embolization during pregnancy. CASE: A 37-year-old pregnant woman presented with profuse painless vaginal blood loss at a gestational age of 27 weeks. Ultrasonography and magnetic resonance imaging indicated a left-sided uterine artery pseudoaneurysm. Selective embolization of the pseudoaneurysm was performed. Blood loss ceased allowing the pregnancy to continue until term. CONCLUSION: Endovascular embolization is a feasible therapeutic option for a uterine artery pseudoaneurysm during pregnancy without compromising fetoplacental perfusion.


BMC Pregnancy and Childbirth | 2009

Assessment of perinatal outcome after sustained tocolysis in early labour (APOSTEL-II trial)

Carolien Roos; Liesbeth Scheepers; Kitty W. M. Bloemenkamp; Annemiek Bolte; Jérôme Cornette; Jan B. Derks; Hans Duvekot; Jim van Eyck; Joke H. Kok; Anneke Kwee; Ashley Merien; Brent C. Opmeer; Marielle van Pampus; Dimitri Papatsonis; Martina Porath; Joris A. M. van der Post; Sicco Scherjon; Krystyne Sollie; Marc Spaanderman; Sylvia M. C. Vijgen; Christine Willekes; Ben Willem J. Mol; Fred K. Lotgering

BackgroundPreterm labour is the main cause of perinatal morbidity and mortality in the Western world. At present, there is evidence that tocolysis for 48 hours is useful in women with threatened preterm labour at least before 32 weeks. This allows transfer of the patient to a perinatal centre, and maximizes the effect of corticosteroids for improved neonatal survival. It is questionable whether treatment with tocolytics should be maintained after 48 hours.Methods/DesignThe APOSTEL II trial is a multicentre placebo-controlled study. Pregnant women admitted for threatened preterm labour who have been treated with 48 hours corticosteroids and tocolysis will be eligible to participate in the trial between 26+0 and 32+2 weeks gestational age. They will be randomly allocated to nifedipine (intervention) or placebo (control) for twelve days or until delivery, whatever comes first.Primary outcome is a composite of perinatal death, and severe neonatal morbidity up to evaluation at 6 months after birth. Secondary outcomes are gestational age at delivery, number of days in neonatal intensive care and total days of the first 6 months out of hospital. In addition a cost-effectiveness analysis will be performed. Analysis will be by intention to treat. The power calculation is based on an expected 11% difference in adverse neonatal outcome. This implies that 406 women have to be randomised (two sided test, β 0.2 at alpha 0.05).DiscussionThis trial will provide evidence as to whether maintenance tocolysis reduces severe perinatal morbidity and mortality in women with threatened preterm labour before 32 weeks.Trial RegistrationClinical trial registration: http://www.trialregister.nl, NTR 1336, date of registration: June 3rd 2008.


American Journal of Perinatology Reports | 2015

Predictive Factors for Delivery within 7 Days after Successful 48-Hour Treatment of Threatened Preterm Labor

Carolien Roos; Ewoud Schuit; Hubertina C. J. Scheepers; Kitty W. M. Bloemenkamp; Antoinette C. Bolte; Hans Duvekot; Jim van Eyck; Joke H. Kok; Anneke Kwee; Ashley Merien; Brent C. Opmeer; Martijn A. Oudijk; Marielle van Pampus; Dimitri Papatsonis; Martina Porath; Krystyna M. Sollie; Marc Spaanderman; Sylvia M. C. Vijgen; Christine Willekes; Fred K. Lotgering; Joris A. M. van der Post; Ben Willem J. Mol

Objective The aim of this study was to assess which characteristics and results of vaginal examination are predictive for delivery within 7 days, in women with threatened preterm labor after initial treatment. Study Design A secondary analysis of a randomized controlled trial on maintenance nifedipine includes women who remained undelivered after threatened preterm labor for 48 hours. We developed one model for women with premature prelabor rupture of membranes (PPROM) and one without PPROM. The predictors were identified by backward selection. We assessed calibration and discrimination and used bootstrapping techniques to correct for potential overfitting. Results For women with PPROM (model 1), nulliparity, history of preterm birth, and vaginal bleeding were included in the multivariable analysis. For women without PPROM (model 2), maternal age, vaginal bleeding, cervical length, and fetal fibronectin (fFN) status were in the multivariable analysis. Discriminative capability was moderate to good (c-statistic 0.68; 95% confidence interval [CI] 0.60–0.77 for model 1 and 0.89; 95% CI, 0.84–0.93 for model 2). Conclusion PPROM and vaginal bleeding in the current pregnancy are relevant predictive factors in all women, as are maternal age, cervical length, and fFN in women without PPROM and nulliparity, history of preterm birth in women with PPROM.


Journal of Maternal-fetal & Neonatal Medicine | 2016

Fetal fibronectin status and cervical length in women with threatened preterm labor and the effectiveness of maintenance tocolysis

Carolien Roos; Jolande Y. Vis; Hubertina C. J. Scheepers; Kitty W. M. Bloemenkamp; Hans Duvekot; Jim van Eyck; Christianne J.M. de Groot; Joke H. Kok; Brent C. Opmeer; Martijn A. Oudijk; Dimitri Papatsonis; Martina Porath; Krystyna M. Sollie; Marc Spaanderman; Fred K. Lotgering; Joris A. M. van der Post; Ben Willem J. Mol

Abstract Objective: To assess the effect of maintenance tocolysis in women who are at high or low risk for preterm delivery according to fetal fibronectin (fFN) status and cervical length (CL). Study design: We compared the risk of preterm delivery in fFN pos and fFN neg women and in women with a CL <15 mm and ≥15 mm, by using the Cox regression. Differences between the effectiveness of maintenance tocolysis in high- and low-risk women were assessed by using an interaction term. Results: 122 fFN tests were taken, of which 50 were fFN pos. CL was measured in 236 women, of whom 52 women had a CL <15 mm. The median gestational age at delivery was lower in fFN pos women; fFN pos women had a higher hazard for preterm delivery at any point of time (HR 4.7; 95% CI 2.9 to 7.6). Comparable results were seen for CL. Neither fFN status nor CL did alter the effect of maintenance tocolysis, which was ineffective in the total randomized group, on the risk of preterm delivery (p for interaction = 0.87 for fFN and 0.18 for CL). Conclusion: Maintenance tocolytic therapy with nifedipine is ineffective and not dependent on fFN or CL status.


European Journal of Obstetrics & Gynecology and Reproductive Biology | 2015

Behavioural and neurodevelopmental outcome of 2-year-old children after preterm premature rupture of membranes: follow-up of a randomised clinical trial comparing induction of labour and expectant management

Jantien van der Heyden; Christine Willekes; Anneloes L. van Baar; Aleid G. van Wassenaer-Leemhuis; Eva Pajkrt; Martijn A. Oudijk; Martina Porath; Hans Duvekot; Kitty W. M. Bloemenkamp; Mariette Groenewout; Mallory Woiski; Bas Nij Bijvank; Caroline J. Bax; Janneke van 't Hooft; Marko Sikkema; Bettina M.C. Akerboom; T. Mulder; Jan G. Nijhuis; Ben W.J. Mol; David van der Ham

OBJECTIVE We recently reported that induction of labour does not improve short term neonatal outcome in women with late preterm premature rupture of membranes (PPROM) as compared to expectant management (PPROMEXIL trial). In this study the neurodevelopmental and behavioural outcome of the children from this trial at 2 years of age was studied. STUDY DESIGN We studied outcome of offspring of women randomised in the PPROMEXIL study. These women had >24h of ruptured membranes and were between 34 and 37 weeks of pregnancy when they were randomised to induction of labour (IoL) or expectant management (EM). Two years after delivery, the parents received the ages and stages questionnaire (ASQ), the child behaviour checklist (CBCL) and a general questionnaire. RESULTS Follow-up data were obtained from 234 children (121 after IoL, 113 after EM, response rate 59% (44% of the original 532 randomised women)). In the IoL group 16 children (14%) had an abnormal score in ≥1 domains of the ASQ, versus 27 (26%) in the EM group (difference in percentage -11.4 (95% CI -21.9 to -0.98; p=0.033)). For the CBCL, an abnormal score was found in 13% (n=15) in the IoL group and in 15% (n=16) in the EM group (difference in percentage -2.13 (95% CI -11.2 to 6.94; p=0.645)). CONCLUSION Although a policy of induction of labour in women with late PPROM does not improve short term neonatal outcome, it might be associated with a decrease in neurodevelopmental difficulties at the age of two years as compared to expectant management. Expectant management did not lead to a difference in behavioural problems.


Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health | 2012

OS109. Lifestyle intervention after complicated pregnancy successfully improves saturated fat-intake, but not exercise and smoking habits: results of the pro-active study.

Durk Berks; Meeke Hoedjes; Hein Raat; A. Franx; Hans Duvekot; E.A.P. Steegers

INTRODUCTION Women with a pregnancy complicated by preeclampsia, intra-uterine growth restriction and/or gestational diabetes are at increased risk of future cardiovascular and metabolic disease. Lifestyle intervention may help these women to effectively lower these risks. OBJECTIVES To test if offering lifestyle intervention after a complicated pregnancy significantly improves saturated fat-intake and exercise (primary objectives) and/or smoking habits (secondary objective). METHODS The Pro-Active study (Postpartum Rotterdam Appraisal of Cardiovascular health and Tailored Intervention) is a feasibility study to develop and evaluate a postpartum lifestyle intervention program. In a prospective case-control setting we tested the effect of the lifestyle intervention. Women were included between April 2007 and August 2009. They were eligible if ⩾18 years old at time of inclusion, being able to understand and speak the Dutch language and not having pre-existing conditions that could interfere with the lifestyle intervention. Cases were offered lifestyle intervention by a trained counsellor between 6 and 10 months postpartum. During 3 private sessions, mainly exercise and fat-intake and to some extend smoking habits were discussed and aims were made to improve lifestyle. Controls did not receive these sessions, but were not restricted to improve lifestyle on their own. Lifestyle habits were scored at 6 and 13 months postpartum. For saturated fat-intake we used the Maastricht Fatlist. For exercise we used the International Physical Activity Questionnaire (IPAQ). For smoking habits we used a short version of the questionnaire of STIVORO (the Dutch anti-smoking association). We also performed a formative evaluation of the intervention program. RESULTS During our study 1121 women gave birth after a complicated pregnancy. 490 Women were eligible for the study of which 240 women (49%) gave informed consent to participate. 56 Women (23%) were lost-to-follow-up, leaving 186 women for the analysis. Between 6 and 13 months postpartum saturated fat-intake was significantly reduced by 3.6g/day (95%>CI 1.8-5.4) in cases compared to controls. Exercise was improved in cases compared to controls, but it did not reach significance (277 METs (-2699-3254)). Although smoking decreased from 14.5% to 10.4% in cases, it was not significant and comparable to the decrease in controls (15.0% to 8.4%). The formative evaluation showed that the most important motivator to improve lifestyle was the increased risk of future cardiovascular and metabolic disease (70%) and the increased risk for recurrence in a next pregnancy (57%). Main barriers were an already busy life (40%), distance (35%) and duration (38%) of travelling to the hospital and to early postpartum to pay attention to lifestyle (26%). CONCLUSION Lifestyle intervention after complicated pregnancy may be effective in improving saturated fat-intake. Other interventions, specially aimed at postpartum women, are needed to improve exercise and smoking habits. More research is needed to develop lifestyle intervention program specifically aimed at these women. New possibilities of multimedia are promising.


Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health | 2013

PP045. Different associations between phenotypes of preeclampsia and thrombophilias

Durk Berks; Hans Duvekot; Hillal Basalan; Eric A.P. Steegers; Willy Visser

INTRODUCTION Studies on the association of preeclampsia (PE) with thrombophilias (TRPH) are conflicting. Clinical heterogeneity of PE may be one of the explanations. OBJECTIVES The present study addresses the question whether different phenotypes of PE are associated with subtypes of TRPH. METHODS In this retrospective cohort study between 1985 until 2010 women with PE were offered postpartum screening for the following TRPH: anti-phospholipid antibodies (APA), APC-resistance, protein C deficiency and protein S deficiency (PSD), hyperhomocysteinemia (HCY), factor V Leiden and Prothrombin gene mutation. RESULTS 890 Women with PE were screened for TRPH. 49% Also had HELLP, 60% had IUGR, 71% delivered before the 34th week. One or more TRPH factors were present in 31% of the women. Severe PE was associated with PSD (p=0.01). IUGR (p<0.01) was associated with APA (p<0.01) and PSD (P=0.03). Early onset PE was associated with APA (P, 0.01). More than 10% of placental infarction was associated with APA (p<0.01). Placental weight below the 5th percentile was associated with HCY (p=0.03). Other phenotypes of PE and TRPH were not associated. CONCLUSION Severe and early onset PE, especially if complicated by IUGR, are associated with APA and PSD. Other phenotypes of PE, especially HELLP syndrome, were not associated with TRPH. We advise to screen for APA and PSD after severe and early onset PE, especially if complicated by IUGR. We do not recommend screening for TRPH in other phenotypes of PE.


Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health | 2013

PP087. Multicenter external validation and recalibration of a model for preconceptional prediction of recurrent early-onset preeclampsia.

Sander M. J. van Kuijk; Denise Delahaije; Carmen D. Dirksen; Hubertina C. J. Scheepers; Marc Spaanderman; Wessel Ganzevoort; Hans Duvekot; M.A. Oudijk; M.G. van Pampus; Peter von Dadelszen; Louis L. H. Peeters; Luc Smiths

INTRODUCTION In an earlier paper we reported on the development of a model aimed at the prediction of preeclampsia recurrence, based on variables obtained before the next pregnancy (fasting glucose, BMI, previous birth of a small-for-gestational-age infant, duration of the previous pregnancy, and the presence of hypertension). OBJECTIVE To externally validate and recalibrate the prediction model for the risk of recurrence of early-onset preeclampsia. METHODS We collected data about course and outcome of the next ongoing pregnancy in 229 women with a history of early-onset preeclampsia. Recurrence was defined as preeclampsia requiring delivery before 34 weeks. We computed risk of recurrence and assessed model performance. In addition, we constructed a table comparing sensitivity, specificity, and predictive values for different suggested risk-thresholds. RESULTS Early-onset preeclampsia recurred in 6.6% of women. The model systematically underestimated recurrence risk. The models discriminative ability was modest, the area under the receiver operating characteristic curve was 58.9% (95% CI: 45.1 - 72.7). Using relevant risk-thresholds, the model created groups that were only moderately different in terms of their average risk of recurrent preeclampsia (Table 1). CONCLUSION Compared to an AUC of 65% in the development cohort, the discriminate ability of the model was diminished. It had inadequate performance to classify women into clinically relevant risk groups.


The Lancet | 2013

Cervical pessaries for prevention of preterm birth in women with a multiple pregnancy (ProTWIN): a multicentre, open-label randomised controlled trial

Sophie Liem; Ewoud Schuit; Maud Hegeman; Joke Bais; Karin de Boer; Kitty W. M. Bloemenkamp; Jozien T. J. Brons; Hans Duvekot; Bas Nij Bijvank; Maureen Franssen; Ingrid Gaugler; Irene de Graaf; Martijn A. Oudijk; Dimitri Papatsonis; Paula Pernet; Martina Porath; Liesbeth Scheepers; Marko Sikkema; Jan Sporken; Harry Visser; Wim van Wijngaarden; Mallory Woiski; Marielle van Pampus; Ben Willem J. Mol; Dick J. Bekedam


BMC Pregnancy and Childbirth | 2014

Nifedipine versus atosiban in the treatment of threatened preterm labour (Assessment of Perinatal Outcome after Specific Tocolysis in Early Labour : APOSTEL III-Trial)

Elvira O.G. van Vliet; Ewoud Schuit; Karst Y. Heida; Brent C. Opmeer; Marjolein Kok; Wilfried Gyselaers; Martina Porath; Mallory Woiski; Caroline J. Bax; Kitty W. M. Bloemenkamp; Hubertina C. J. Scheepers; Yves Jaquemyn; Erik van Beek; Hans Duvekot; Maureen Franssen; Bas Nij Bijvank; Joke H. Kok; Arie Franx; Ben Willem J. Mol; Martijn A. Oudijk

Collaboration


Dive into the Hans Duvekot's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Mallory Woiski

Radboud University Nijmegen

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Marc Spaanderman

Maastricht University Medical Centre

View shared research outputs
Researchain Logo
Decentralizing Knowledge